BRPI0416873A - derivados de benzoxazina e usos dos mesmos - Google Patents
derivados de benzoxazina e usos dos mesmosInfo
- Publication number
- BRPI0416873A BRPI0416873A BRPI0416873-9A BRPI0416873A BRPI0416873A BR PI0416873 A BRPI0416873 A BR PI0416873A BR PI0416873 A BRPI0416873 A BR PI0416873A BR PI0416873 A BRPI0416873 A BR PI0416873A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- benzoxazine derivatives
- formula
- benzoxazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
"DERIVADOS DE BENZOXAZINA E USOS DOS MESMOS". A presente invenção proporciona compostos de fórmula (I): ou sais farmaceuticamente aceitáveis, solvatos ou pró-drogas dos compostos, onde R¬ 1¬, R¬ 2¬, R¬ 3¬, R¬ 4¬,R¬ 5¬, R¬ 6¬, R¬ 7¬, R¬ 8¬,R¬ 9¬, X, Y e m são como definidos neste relatório. Também proporcionado são composições contendo esses compostos, o uso desses compostos para a produção de medicamentos, bem como métodos para preparar o composto de fórmula (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52837803P | 2003-12-09 | 2003-12-09 | |
PCT/EP2004/013557 WO2005058847A1 (en) | 2003-12-09 | 2004-11-30 | Benzoxazine derivatives and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0416873A true BRPI0416873A (pt) | 2007-02-27 |
Family
ID=34699863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416873-9A BRPI0416873A (pt) | 2003-12-09 | 2004-11-30 | derivados de benzoxazina e usos dos mesmos |
Country Status (21)
Country | Link |
---|---|
US (1) | US7202241B2 (pt) |
EP (1) | EP1694656B1 (pt) |
JP (1) | JP4527730B2 (pt) |
KR (1) | KR100827915B1 (pt) |
CN (1) | CN100532369C (pt) |
AR (1) | AR046753A1 (pt) |
AT (1) | ATE371653T1 (pt) |
AU (1) | AU2004299201B2 (pt) |
BR (1) | BRPI0416873A (pt) |
CA (1) | CA2547764A1 (pt) |
CO (1) | CO5700768A2 (pt) |
DE (1) | DE602004008668T2 (pt) |
ES (1) | ES2291984T3 (pt) |
IL (1) | IL175817A0 (pt) |
MY (1) | MY145576A (pt) |
NO (1) | NO20062491L (pt) |
NZ (1) | NZ547120A (pt) |
RU (1) | RU2354651C2 (pt) |
TW (1) | TW200522953A (pt) |
WO (1) | WO2005058847A1 (pt) |
ZA (1) | ZA200604725B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7504395B2 (en) * | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
ES2643615T3 (es) * | 2004-09-30 | 2017-11-23 | F. Hoffmann-La Roche Ag | Composiciones y métodos para el tratamiento de trastornos cognitivos |
US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
US20090054453A1 (en) * | 2006-03-17 | 2009-02-26 | Lilian Alcaraz | Novel Tetralins as 5-HT6 Modulators |
CL2007003044A1 (es) * | 2006-10-24 | 2008-07-04 | Wyeth Corp | Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros. |
WO2011023753A1 (en) * | 2009-08-27 | 2011-03-03 | Glaxo Group Limited | Benzoxazine derivatives as glycine transport inhibitors |
CN101836993B (zh) | 2010-05-20 | 2011-06-22 | 山东大学 | 2,3-二氢-3-羟甲基-6-氨基-[1,4]-苯并噁嗪在制备诱导胚胎干细胞向血管内皮细胞分化药物中的应用 |
CN102060810B (zh) * | 2010-12-20 | 2012-07-04 | 金坛市爱特生物科技有限公司 | 一种n-叔丁氧羰基-哌嗪的提纯方法 |
CN106132422A (zh) | 2014-02-27 | 2016-11-16 | 莱斯拉公司 | 使用视黄酸受体相关孤儿受体γ的激动剂的过继细胞疗法&相关治疗方法 |
EP3209641A4 (en) | 2014-05-05 | 2018-06-06 | Lycera Corporation | Benzenesulfonamido and related compounds for use as agonists of ror and the treatement of disease |
AU2015256190B2 (en) | 2014-05-05 | 2019-08-15 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease |
CA2953004C (en) | 2014-07-08 | 2023-02-21 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
CA2982847A1 (en) | 2015-05-05 | 2016-11-10 | Lycera Corporation | Dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror.gamma. and the treatment of disease |
KR20180025894A (ko) * | 2015-06-11 | 2018-03-09 | 라이세라 코퍼레이션 | Rory의 작용제로서 사용하기 위한 아릴 디히드로-2h-벤조[b][1,4]옥사진 술폰아미드 및 관련 화합물 및 질환의 치료 |
CN109568321B (zh) * | 2019-01-14 | 2022-02-22 | 山东轩竹医药科技有限公司 | RORγ调节剂 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8803419D0 (en) * | 1988-02-15 | 1988-03-16 | Erba Carlo Spa | 1 4-benzoxazine & 1 4-benzothiazine derivatives & process for their preparation |
GB9507203D0 (en) | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
HUP0001123A3 (en) | 1997-04-18 | 2002-04-29 | Smithkline Beecham Plc | Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity |
US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
WO2001057003A1 (en) | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa |
DE60303376T2 (de) * | 2002-05-13 | 2006-11-16 | F. Hoffmann-La Roche Ag | Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen |
DK1562918T3 (da) * | 2002-11-08 | 2008-05-05 | Hoffmann La Roche | Substituerede benzoxazinoner og anvendelser deraf |
-
2004
- 2004-11-30 WO PCT/EP2004/013557 patent/WO2005058847A1/en active IP Right Grant
- 2004-11-30 NZ NZ547120A patent/NZ547120A/en unknown
- 2004-11-30 DE DE602004008668T patent/DE602004008668T2/de active Active
- 2004-11-30 RU RU2006124513/04A patent/RU2354651C2/ru not_active IP Right Cessation
- 2004-11-30 BR BRPI0416873-9A patent/BRPI0416873A/pt not_active Application Discontinuation
- 2004-11-30 KR KR1020067011286A patent/KR100827915B1/ko not_active IP Right Cessation
- 2004-11-30 AT AT04820410T patent/ATE371653T1/de active
- 2004-11-30 CN CNB2004800368183A patent/CN100532369C/zh not_active Expired - Fee Related
- 2004-11-30 ES ES04820410T patent/ES2291984T3/es active Active
- 2004-11-30 CA CA002547764A patent/CA2547764A1/en not_active Abandoned
- 2004-11-30 JP JP2006543432A patent/JP4527730B2/ja not_active Expired - Fee Related
- 2004-11-30 EP EP04820410A patent/EP1694656B1/en active Active
- 2004-11-30 AU AU2004299201A patent/AU2004299201B2/en not_active Ceased
- 2004-12-07 MY MYPI20045047A patent/MY145576A/en unknown
- 2004-12-07 AR ARP040104555A patent/AR046753A1/es not_active Application Discontinuation
- 2004-12-08 TW TW093137995A patent/TW200522953A/zh unknown
- 2004-12-09 US US11/008,310 patent/US7202241B2/en not_active Expired - Fee Related
-
2006
- 2006-05-22 IL IL175817A patent/IL175817A0/en unknown
- 2006-05-31 NO NO20062491A patent/NO20062491L/no not_active Application Discontinuation
- 2006-06-08 ZA ZA200604725A patent/ZA200604725B/xx unknown
- 2006-06-12 CO CO06056964A patent/CO5700768A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ547120A (en) | 2009-02-28 |
KR20060097758A (ko) | 2006-09-15 |
JP2007513904A (ja) | 2007-05-31 |
CO5700768A2 (es) | 2006-11-30 |
ES2291984T3 (es) | 2008-03-01 |
CN1890227A (zh) | 2007-01-03 |
ATE371653T1 (de) | 2007-09-15 |
EP1694656B1 (en) | 2007-08-29 |
KR100827915B1 (ko) | 2008-05-07 |
CA2547764A1 (en) | 2005-06-30 |
US20050124613A1 (en) | 2005-06-09 |
AU2004299201A1 (en) | 2005-06-30 |
DE602004008668D1 (de) | 2007-10-11 |
MY145576A (en) | 2012-02-29 |
US7202241B2 (en) | 2007-04-10 |
WO2005058847A1 (en) | 2005-06-30 |
RU2354651C2 (ru) | 2009-05-10 |
AR046753A1 (es) | 2005-12-21 |
IL175817A0 (en) | 2006-10-05 |
NO20062491L (no) | 2006-09-06 |
ZA200604725B (en) | 2007-12-27 |
EP1694656A1 (en) | 2006-08-30 |
DE602004008668T2 (de) | 2008-06-12 |
CN100532369C (zh) | 2009-08-26 |
TW200522953A (en) | 2005-07-16 |
JP4527730B2 (ja) | 2010-08-18 |
RU2006124513A (ru) | 2008-01-27 |
AU2004299201B2 (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0302811D0 (sv) | Novel compounds | |
ECSP066643A (es) | PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2 | |
BR0316081A (pt) | Derivados de 2-piridona como inibidores de elastase de neutrófilo | |
SE0202463D0 (sv) | Novel compounds | |
BRPI0414570A (pt) | derivados de 2-piridona como inibidores de elastase de neutrófilo e seu uso | |
UY30206A1 (es) | Derivados de diamina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
BRPI0416873A (pt) | derivados de benzoxazina e usos dos mesmos | |
UY27226A1 (es) | Pirazolopirimidinas como agentes terapéuticos | |
UY30316A1 (es) | Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
SE0202133D0 (sv) | Novel compounds | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
BRPI0413094A (pt) | derivados de quinolina e seu uso em terapia | |
UY27803A1 (es) | Derivados de benzoxazina y usos de los mismos. | |
ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
UY27424A1 (es) | Agentes antidiabéticos | |
BR0315302A (pt) | Benzoxazinonas substituìdas e seus usos | |
SE0303541D0 (sv) | New compounds | |
DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0302546D0 (sv) | New compounds | |
PA8589801A1 (es) | Aminoalcoxiindoles | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0303280D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |